IQV
IQVIA Holdings Inc.NYSEHealthcare$173.26+0.50%ClosedMarket Cap: $29.40B
As of 2026-04-06
Valuation
P/E (TTM)
21.62
PEG
—
P/B
4.53
P/S
1.80
EV/EBITDA
12.59
DCF Value
$241.68
FCF Yield
8.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
26.3%
Operating Margin
14.0%
Net Margin
8.3%
ROE
22.3%
ROA
16.3%
ROIC
8.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $4.36B | 6.7% | $732.0M | $514.0M | $2.99 | — |
| FY 2025 | $16.31B | 26.3% | $2.29B | $1.36B | $7.84 | — |
| Q3 2025 | $4.10B | 33.5% | $553.0M | $331.0M | $1.93 | — |
| Q2 2025 | $4.02B | 32.9% | $506.0M | $266.0M | $1.54 | — |
| Q1 2025 | $3.83B | 33.9% | $496.0M | $249.0M | $1.40 | — |
| Q4 2024 | $3.96B | 34.8% | $626.0M | $437.0M | $2.42 | — |
| FY 2024 | $15.40B | 34.9% | $2.20B | $1.37B | $7.49 | — |
| Q3 2024 | $3.90B | 35.4% | $550.0M | $285.0M | $1.55 | — |
| Q2 2024 | $3.81B | 27.7% | $548.0M | $363.0M | $1.97 | — |
| Q1 2024 | $3.74B | 34.6% | $506.0M | $288.0M | $1.56 | — |
| Q4 2023 | $3.87B | 35.9% | $501.0M | $469.0M | $2.54 | — |
| FY 2023 | $14.98B | 35.0% | $1.98B | $1.36B | $7.29 | — |